Company profile: BD Biosciences
1.1 - Company Overview
Company description
- Provider of flow cytometers; research cell analyzers and cell sorters; clinical cell analyzers; single-cell multiomics systems; and automated sample preparation systems for flow cytometry, supporting applications in immunology, cancer research, diagnostics, and clinical research.
Products and services
- Clinical Cell Analyzers: Clinical-grade flow cytometry systems engineered for clinical applications, delivering automation and standardization for diagnostic and clinical research across routine workflows
- Flow Cytometers: Laser-based instruments designed for analyzing physical and chemical characteristics of particles in a fluid as they pass through at least one laser
- Single-Cell Multiomics Systems: Modular instruments that allow simultaneous analysis of multiple biomolecule types at the single-cell level for comprehensive cellular profiling in research settings
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BD Biosciences
Singulex
HQ: United States
Website
- Description: Provider of direct molecular detection and cardiovascular monitoring solutions, including the Singulex Clarity System, an automated in vitro diagnostics platform using Single Molecule Counting technology for precise, ultra-low-level biomarker measurement across a 6-log reporting range, and the Singulex cTnI Assay for femtogram-per-milliliter cardiac troponin I quantitation to aid cardiovascular disease diagnosis and management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Singulex company profile →
Incept Biosystems
HQ: United States
Website
- Description: Provider of innovative microscale technologies that provide fertility specialists breakthrough capabilities to treat infertility, improving the in vitro manipulation, performance, and viability of high-value cells, with a mission to set the standard for next-generation clinical devices for Assisted Reproductive.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Incept Biosystems company profile →
Cytoo
HQ: France
Website
- Description: Provider of life science research products and cell-based assay solutions that make cellular analysis robust and reliable by decreasing cell variability, including high content screening (96-well, 384 format coming), micropatterning technology, OncoSpheres 3D spheroids, Arena and custom chips, and standard, starter, and motility plates for high-throughput, multiplexed analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytoo company profile →
A4Cell
HQ: Spain
Website
- Description: Provider of SPAchip technology using intracellular silicon microchips to monitor living single cells and cellular pathways in real time without affecting viability. Offers kits: CytoCHECK pH Green, pH Red, Calcium; CytoTRACK pH Dual-Detection; and SpheroCHECK pH Green for 3D spheroids, enabling precise single-cell physiology monitoring to improve cell study data for understanding disease behavior.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full A4Cell company profile →
Luxendo
HQ: Germany
Website
- Description: Provider of proprietary light-sheet fluorescence microscopy instruments based on Single Plane Illumination Microscopy (SPIM). Offers MuVi SPIM, InVi SPIM Lattice Pro, LCS SPIM, and TruLive3D Imager, plus Acquifer HIVE for centralized data storage and computing and LuxBundle Software for acquisition, viewing, and post-processing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Luxendo company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BD Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BD Biosciences
2.2 - Growth funds investing in similar companies to BD Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BD Biosciences
4.2 - Public trading comparable groups for BD Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →